# FDA Inspection 1166937 - Reproductive Resources Inc. - March 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/reproductive-resources-inc/c103e6a4-9040-4e76-b5fa-6c73ccac0f78
Source feed: FDA_Inspections

> FDA Inspection 1166937 for Reproductive Resources Inc. on March 10, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166937
- Company Name: Reproductive Resources Inc.
- Inspection Date: 2022-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1223217 - 2023-11-14](https://www.keypedia.com/records/fda_inspections/reproductive-resources-inc/aaa50d02-37f8-4432-8bb9-b3bbe03dface)
- [FDA Inspection 1166937 - 2022-03-10](https://www.keypedia.com/records/fda_inspections/reproductive-resources-inc/e61e8113-05b2-448f-a61d-a6149ae1eeba)
- [FDA Inspection 1095604 - 2019-04-01](https://www.keypedia.com/records/fda_inspections/reproductive-resources-inc/c249bbbe-d576-479d-b56d-a5af40a51063)
- [FDA Inspection 1095604 - 2019-04-01](https://www.keypedia.com/records/fda_inspections/reproductive-resources-inc/70a47df5-11f2-46ec-870c-5ef7a694783c)
- [FDA Inspection 1007022 - 2017-04-04](https://www.keypedia.com/records/fda_inspections/reproductive-resources-inc/ce380cdd-2e63-49fb-8c85-48499cd13625)

Company: https://www.keypedia.com/companies/reproductive-resources-inc/b27cddda-a63d-43e3-b8cd-c85572ccf4ca

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d